נפ-פנזל dc וטרינרי
intervet ( israel) ltd - dihydrostreptomycin sulfate; nafcillin as nafcillin sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin sulfate 100 mg / 3 g; nafcillin as nafcillin sodium 100 mg / 3 g
גנטז'קט 50 וטרינרי
abic veterinary products ltd - gentamicin as sulfate - תמיסה - gentamicin as sulfate 50 mg/ml
נפפנזל דיסי וטרינרי
intervet ( israel) ltd - dihydrostreptomycin as sulfate; nafcillin as sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin as sulfate 100 mg / 3 g; nafcillin as sodium 100 mg / 3 g
קלופידוגרל טבע
teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or
קלופידוגרל טבע
teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or
פיקו סלקס קרנברי
ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - citric acid anhydrous 12 g; magnesium oxide 3.5 g; sodium picosulfate 10 mg - sodium picosulfate, combinations
קלופידוגרל טבע
teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel
קרסמבה 100 מג כמוסות
pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - קפסולה קשיחה - isavuconazole as sulfate 100 mg - isavuconazole
קלארינז רפטאבס
bayer israel ltd - loratadine; pseudoephedrine sulfate - טבליות בשחרור ממושך - loratadine 5 mg; pseudoephedrine sulfate 120 mg - loratadine - loratadine - relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.
ונטולין טבליות 2 מג
glaxo smith kline (israel) ltd - salbutamol as sulfate - טבליה - salbutamol as sulfate 2 mg - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types, chronic bronchitis, emphysema.